Clinical trials
Observational Multiple Myeloma trials in Greece
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 5 |
| Unknown status | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Pharmaceutica N.V., Belgium | 3 |
| Genesis Pharma S.A. | 2 |
| Takeda | 2 |
| University of Athens | 2 |
| AbbVie | 1 |
| Amgen | 1 |
| European Myeloma Network B.V. | 1 |
| Janssen-Cilag Ltd. | 1 |
| JaxBio Ltd | 1 |
| Notable Labs | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 17 |
| Leukemia, Myeloid, Acute | 2 |
| Myelodysplastic Syndromes | 2 |
| Recurrence | 2 |
| COVID-19 | 1 |
| Coronavirus Infections | 1 |
| Hematologic Neoplasms | 1 |
| Hodgkin Disease | 1 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 |
| Leukemia, Plasma Cell | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.